Revenue breakdown: Development Service (68.2%), Other Revenues (17.6%), Product Sales (14.2%).
8-K/A
Onconetix, Inc. appointed David White as Chief Executive Officer effective March 18, 2026, with a monthly base salary of $21,700 under a new employment agreement. The Board accepted Timothy Ramdeen's resignation effective March 19, 2026, appointed Sammy Dorf as a director and Audit Committee member, and reduced compensation for Karina Fedasz by $5,000 monthly and Andrew Oakley by $26,000.